Harbour Capital Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
+2,865
New +$244K 0.04% 285
2025
Q2
Sell
-5,020
Closed -$362K 297
2025
Q1
$362K Hold
5,020
0.09% 201
2024
Q4
$416K Sell
5,020
-70
-1% -$5.52K 0.09% 196
2024
Q3
$359K Buy
+5,090
New +$359K 0.08% 212
2022
Q2
Sell
-3,020
Closed -$223K 226
2022
Q1
$223K Hold
3,020
0.06% 209
2021
Q4
$218K Hold
3,020
0.05% 226
2021
Q3
$231K Buy
+3,020
New +$242K 0.06% 222

Other funds holding GMED

Harbour Capital Advisors's GMED Position: Q2 2026 in Review

Harbour Capital Advisors opened a new position in Globus Medical (GMED) in Q2 2026: 2,865 shares worth $224K. The stake represents 0.04% of the portfolio and ranks #285 among its holdings. This is a return to the name: Harbour Capital Advisors previously reported a position in GMED as recently as Q1 2025.

Harbour Capital Advisors first reported a position in GMED in Q3 2021 and has held it in 7 quarters since. The position peaked at $416K in Q4 2024. 82 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Harbour Capital Advisors held 2,865 shares of Globus Medical worth $224K as of Q2 2026.
  • Globus Medical was a new Harbour Capital Advisors position in Q2 2026.
  • Globus Medical made up 0.04% of Harbour Capital Advisors's portfolio in Q2 2026, its #285 holding.
  • Harbour Capital Advisors first reported a position in Globus Medical in Q3 2021 and has held it in 7 quarters since.
  • Harbour Capital Advisors's Globus Medical position peaked at $416K in Q4 2024.
  • 82 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Harbour Capital Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.